Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Ohio State University
mi
from
Columbus, OH
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Los Robles
mi
from
Thousand Oaks, CA
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Los Robles
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Florida Cancer Specialists
mi
from
Ft. Myers, FL
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Florida Cancer Specialists
mi
from
Ft. Myers, FL
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Woodlands Medical Specialists
mi
from
Pensacola, FL
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
St. Louis Cancer Care
mi
from
Chesterfield, MO
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
St. Louis Cancer Care
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Portsmouth Regional Hospital
mi
from
Portsmouth, NH
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Portsmouth Regional Hospital
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Click here to add this to my saved trials
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated:  2/11/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Enrolling
Updated: 2/11/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Blood Samples From Patients With Cancer Treated on a Clinical Trial to Control Nausea and Vomiting During Donor Stem Cell Transplant
Substance P Follow-up to a Pilot Study of Aprepitant vs Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  2/11/2016
OHSU Knight Cancer Institute
mi
from
Portland, OR
Blood Samples From Patients With Cancer Treated on a Clinical Trial to Control Nausea and Vomiting During Donor Stem Cell Transplant
Substance P Follow-up to a Pilot Study of Aprepitant vs Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 2/11/2016
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
Phase II Study of SOM230 LAR in Combination With Bortezomib and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Status: Enrolling
Updated:  2/11/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
Phase II Study of SOM230 LAR in Combination With Bortezomib and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Status: Enrolling
Updated: 2/11/2016
Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
A Pilot Study to Evaluate the Efficacy and Explore the Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma Patients
Status: Enrolling
Updated:  2/12/2016
University of Maryland/Marlene and Stewart Greenebaum Cancer Center
mi
from
Baltimore, MD
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
A Pilot Study to Evaluate the Efficacy and Explore the Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma Patients
Status: Enrolling
Updated: 2/12/2016
University of Maryland/Marlene and Stewart Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation
Status: Enrolling
Updated:  2/12/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation
Status: Enrolling
Updated: 2/12/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Treatment of Acute Promyelocytic Leukemia (APL) With All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Status: Enrolling
Updated:  2/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Treatment of Acute Promyelocytic Leukemia (APL) With All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Status: Enrolling
Updated: 2/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated:  2/16/2016
Local Institution
mi
from
Los Angeles, CA
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated: 2/16/2016
Local Institution
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated:  2/16/2016
Local Institution
mi
from
San Francisco, CA
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated: 2/16/2016
Local Institution
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated:  2/16/2016
Local Institution
mi
from
New York, NY
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Status: Enrolling
Updated: 2/16/2016
Local Institution
mi
from
New York, NY
Click here to add this to my saved trials
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
Phase Ib Study Evaluating the Safety and Exploring the Molecular and Cytogenetic Response of Combination Therapy With Dasatinib and Ipilimumab in Patients With Chronic or Accelerated Phase Chronic Myeloid Leukemia
Status: Enrolling
Updated:  2/16/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
Phase Ib Study Evaluating the Safety and Exploring the Molecular and Cytogenetic Response of Combination Therapy With Dasatinib and Ipilimumab in Patients With Chronic or Accelerated Phase Chronic Myeloid Leukemia
Status: Enrolling
Updated: 2/16/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma
Status: Enrolling
Updated:  2/17/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma
Status: Enrolling
Updated: 2/17/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
A Phase II Study of Twice Daily Cytarabine and Fludarabine in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
Status: Enrolling
Updated:  2/17/2016
UT MD Anderson Cancer Center
mi
from
Houston, TX
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
A Phase II Study of Twice Daily Cytarabine and Fludarabine in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
Status: Enrolling
Updated: 2/17/2016
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Augusta, GA
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Maywood, IL
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Canton, OH
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Kansas City, KA
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Lexington, KY
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Paducah, KY
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
St Louis, MO
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
Clinical Research Facility
mi
from
Morgantown, WV
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated:  2/17/2016
mi
from
Clayton,
A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia
A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Diffuse Large B Cell Lymphoma
Status: Enrolling
Updated: 2/17/2016
mi
from
Clayton,
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
City of Hope National Medical Center
mi
from
Duarte, CA
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
The University of California, San Diego
mi
from
La Jolla, CA
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Stanford University
mi
from
Palo Alto, CA
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
University of Florida
mi
from
Gainesville, FL
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Johns Hopkins University
mi
from
Baltimore, MD
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
University of Minnesota Twin Cities
mi
from
Minneapolis, MN
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
University of Minnesota Twin Cities
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Sloan-Kettering Institute for Cancer Research
mi
from
New York, NY
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Sloan-Kettering Institute for Cancer Research
mi
from
New York, NY
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Duke University
mi
from
Durham, NC
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated:  2/17/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Blood and Marrow Transplant Clinical Research Network
Blood and Marrow Transplant Clinical Research Network
Status: Enrolling
Updated: 2/17/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials